4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-17-064325
10% owner sold 1,112,446 shares at an average $18.98 ($21,118,120)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…